Yoshinobu Fuke Selected Research

interleukin-18 binding protein

1/2015	Imbalance of interleukin-18 and interleukin-18 binding protein in patients with IgA nephropathy implicating renal vasculopathy.
2/2012	High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus.
6/2011	Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinobu Fuke Research Topics

Disease

5	Type 2 Diabetes Mellitus (MODY) 04/2017 - 05/2010
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2015 - 01/2004
3	Glomerulonephritis 05/2013 - 01/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2012 - 08/2004
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2015 - 01/2008
2	Proteinuria 01/2014 - 01/2007
2	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2013 - 01/2009
2	Diabetic Nephropathies (Diabetic Nephropathy) 04/2012 - 06/2011
2	Lupus Nephritis 02/2012 - 01/2012
2	Peritonitis 06/2010 - 01/2009
2	Diabetes Mellitus 05/2010 - 01/2006
2	Hypertension (High Blood Pressure) 05/2010 - 01/2006
2	Disease Progression 01/2005 - 01/2002
1	Snoring 03/2021
1	Stroke (Strokes) 12/2020
1	Intellectual Disability (Idiocy) 12/2020
1	Atherosclerosis 04/2017
1	Vascular System Injuries 04/2017
1	Vasculitis (Vasculitides) 05/2013
1	Diabetic Angiopathies (Diabetic Angiopathy) 03/2013
1	Obesity 03/2013
1	Inflammation (Inflammations) 03/2013
1	Diabetes Complications 04/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2012
1	Body Weight (Weight, Body) 01/2012
1	Hemorrhage 06/2011
1	Hematoma 06/2011
1	Microscopic Polyangiitis 06/2011
1	Chronic Renal Insufficiency 06/2010
1	Hyperlipidemias (Hyperlipidemia) 05/2010
1	Insulin Resistance 05/2010
1	Ascites 01/2009
1	Fibrosis (Cirrhosis) 01/2008
1	Atrial Fibrillation 01/2005
1	Weight Loss (Weight Reduction) 01/2005
1	Graves Disease (Basedow Disease) 01/2005
1	Tremor (Tremors) 01/2005
1	Hyperthyroidism 01/2005
1	Angioedema 08/2004
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 08/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2002

Drug/Important Bio-Agent (IBA)

4	AdipokinesIBA 04/2017 - 05/2010
4	Interleukin-18 (Interleukin 18)IBA 01/2015 - 06/2011
4	Complement System Proteins (Complement)IBA 01/2014 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 04/2017 - 01/2008
3	interleukin-18 binding proteinIBA 01/2015 - 06/2011
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2013 - 01/2005
3	Peroxidase (Myeloperoxidase)IBA 05/2013 - 01/2005
3	CytokinesIBA 03/2013 - 02/2012
2	Antigen-Antibody Complex (Immune Complex)IBA 02/2012 - 01/2012
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2012 - 10/2010
2	Prednisolone (Predate)FDA LinkGeneric 01/2009 - 01/2005
2	Complement Factor H (Factor H)IBA 01/2007 - 01/2004
1	ReninIBA 03/2021
1	AmidophosphoribosyltransferaseIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 04/2017
1	Biomarkers (Surrogate Marker)IBA 04/2017
1	EnzymesIBA 01/2015
1	ImmunosorbentsIBA 01/2015
1	CreatinineIBA 01/2014
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2014
1	GlucocorticoidsIBA 06/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2013
1	Carrier Proteins (Binding Protein)IBA 02/2012
1	Nylons (Nylon)IBA 01/2012
1	Dipyridamole (Persantine)FDA LinkGeneric 06/2011
1	AutoantibodiesIBA 06/2011
1	Antihypertensive Agents (Antihypertensives)IBA 05/2010
1	PPAR gammaIBA 05/2010
1	AdiponectinIBA 05/2010
1	Telmisartan (Micardis)FDA Link 05/2010
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 05/2010
1	AlbuminsIBA 01/2009
1	Indicators and Reagents (Reagents)IBA 01/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2008
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2007
1	C-Reactive ProteinIBA 01/2006
1	Colloids (Colloid)IBA 08/2004
1	Immunoglobulin E (IgE)IBA 08/2002

Therapy/Procedure

3	Therapeutics 01/2012 - 01/2002
2	Renal Dialysis (Hemodialysis) 01/2012 - 08/2004
1	Peritoneal Dialysis 06/2010
1	Glycemic Control 05/2010